These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25899424)

  • 1. Progressive multiple sclerosis and mood disorders.
    Lorefice L; Fenu G; Trincas G; Moro MF; Frau J; Coghe GC; Cocco E; Marrosu MG; Carta MG
    Neurol Sci; 2015 Sep; 36(9):1625-31. PubMed ID: 25899424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety disorders and their clinical correlates in multiple sclerosis patients.
    Korostil M; Feinstein A
    Mult Scler; 2007 Jan; 13(1):67-72. PubMed ID: 17294613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis.
    Drake MA; Carrá A; Allegri RF; Luetic G
    Neurol India; 2006 Dec; 54(4):370-6. PubMed ID: 17114845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.
    Chwastiak L; Ehde DM; Gibbons LE; Sullivan M; Bowen JD; Kraft GH
    Am J Psychiatry; 2002 Nov; 159(11):1862-8. PubMed ID: 12411220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
    Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
    Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social anxiety in a multiple sclerosis clinic population.
    Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
    Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and anxiety adversely affect cognition in multiple sclerosis.
    Marrie RA; Patel R; Figley CR; Kornelsen J; Bolton JM; Graff L; Mazerolle EL; Marriott JJ; Bernstein CN; Fisk JD;
    Mult Scler Relat Disord; 2019 Jan; 27():164-170. PubMed ID: 30384203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.
    Kroencke DC; Lynch SG; Denney DR
    Mult Scler; 2000 Apr; 6(2):131-6. PubMed ID: 10773860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics
    Holland DP; Schlüter DK; Young CA; Mills RJ; Rog DJ; Ford HL; Orchard K;
    Mult Scler Relat Disord; 2019 Jan; 27():214-222. PubMed ID: 30412819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report.
    Zahoor I; Asimi R; Haq E; Yousuf Wani I
    Mult Scler Relat Disord; 2017 Apr; 13():103-106. PubMed ID: 28427689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is malnutrition a problem for multiple sclerosis patients?
    Sorgun MH; Yucesan C; Tegin C
    J Clin Neurosci; 2014 Sep; 21(9):1603-5. PubMed ID: 24932588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis].
    Shkil'niuk GG; Il'ves AG; Kataeva GV; Prakhova LN; Reznikova TN; Seliverstova NA; Stoliarov ID
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):41-6. PubMed ID: 22677678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
    Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
    Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
    Bergamaschi R; Beghi E; Bosetti C; Ponzio M; Santucci C; Lepore V; Mosconi P; ; Aguglia U; Amato MP; Ancona AL; Ardito B; Avolio C; Balgera R; Banfi P; Barcella V; Barone P; Bellantonio P; Berardinelli A; Bergamaschi R; Bertora P; Bianchi M; Bramanti P; Morra VB; Brichetto G; Brioschi AM; Buccafusca M; Bucello S; Busillo V; Calchetti B; Cantello R; Capobianco M; Capone F; Capone L; Cargnelutti D; Carrozzi M; Cartechini E; Cavaletti G; Cavalla P; Celani MG; Clerici R; Clerico M; Cocco E; Confalonieri P; Coniglio MG; Conte A; Corea F; Cottone S; Crociani P; D'Andrea F; Danni MC; De Luca G; de Pascalis D; De Riz M; De Robertis F; De Rosa G; De Stefano N; Corte MD; Di Sapio A; Docimo R; Falcini M; Falcone N; Fermi S; Ferraro E; Ferrò MT; Fortunato M; Foschi M; Gajofatto A; Gallo A; Gallo P; Gatto M; Gazzola P; Giordano A; Granella F; Grasso MF; Grasso MG; Grimaldi LME; Iaffaldano P; Imperiale D; Inglese M; Iodice R; Leva S; Luezzi V; Lugaresi A; Lus G; Maimone D; Mancinelli L; Maniscalco GT; Marfia GA; Marini B; Marson A; Mascoli N; Massacesi L; Melani F; Merello M; Meucci G; Mirabella M; Montepietra S; Nasuelli D; Nicolao P; Passantino F; Patti F; Peresson M; Pesci I; Piantadosi C; Piras ML; Pizzorno M; Plewnia K; Pozzilli C; Protti A; Quatrale R; Realmuto S; Ribizzi G; Rinalduzzi S; Rini A; Romano S; Romeo M; Ronzoni M; Rossi P; Rovaris M; Salemi G; Santangelo G; Santangelo M; Santuccio G; Sarchielli P; Sinisi L; Sola P; Solaro C; Spitaleri D; Strumia S; Tassinari T; Tonietti S; Tortorella C; Totaro R; Tozzo A; Trivelli G; Ulivelli M; Valentino P; Venturi S; Vianello M; Zaffaroni M; Zarbo R; Trojano M; Battaglia MA; Capobianco M; Pugliatti M; Ulivelli M; Mosconi P; Gasperini C; Patti F; Amato MP; Bergamaschi R; Comi G
    Neurol Sci; 2022 Sep; 43(9):5459-5469. PubMed ID: 35672479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood and anxiety disorders in patients with multiple sclerosis.
    Uguz F; Akpinar Z; Ozkan I; Tokgoz S
    Int J Psychiatry Clin Pract; 2008; 12(1):19-24. PubMed ID: 24916492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.